Back to 
Blackstone Inc.
Blackstone Inc.
AVLN1 quarters
Position history for Blackstone Inc.'s holdings in AVALYN PHARMA INC
Yes. Blackstone holds 97,985 shares of AVLN (Avalyn Pharma), worth $3.2M, as of its Q2 2026 13F filing.
Current Value
$3.2M
Current Shares
97,985
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of AVLN: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., CITADEL ADVISORS LLC